Page last updated: 2024-08-23

pirfenidone and Carotid Arteriopathies, Traumatic

pirfenidone has been researched along with Carotid Arteriopathies, Traumatic in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Backes, A; Braun-Dullaeus, RC; Seay, U; Sedding, DG; Tillmanns, HH1
Bicknell, GR; Margolin, SB; Murphy, GJ; Nicholson, ML; Sandford, R; Waller, JR1

Other Studies

2 other study(ies) available for pirfenidone and Carotid Arteriopathies, Traumatic

ArticleYear
Inhibition of matrix deposition: a new strategy for prevention of restenosis after balloon angioplasty.
    Journal of cardiovascular pharmacology, 2010, Volume: 55, Issue:2

    Topics: Angioplasty, Balloon; Animals; Carotid Artery Injuries; Carotid Artery, Common; Coronary Restenosis; Extracellular Matrix; Male; Pyridones; Rats; Rats, Wistar

2010
Pirfenidone inhibits early myointimal proliferation but has no effect on late lesion size in rats.
    European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery, 2002, Volume: 23, Issue:3

    Topics: Angioplasty, Balloon; Animals; Anti-Inflammatory Agents, Non-Steroidal; Carotid Arteries; Carotid Artery Injuries; Disease Models, Animal; Dose-Response Relationship, Drug; Extracellular Matrix; Gene Expression; Male; Metalloendopeptidases; Pyridones; Rats; Time Factors; Tunica Intima

2002